Sign in to view content

Staring a Clinical Trials Program

David A. Eichenbaum, MD, FASRS

Video
Published 2019

Related

Safety, Tolerability, and Efficacy of Tinlarebant: 24-Month Primary Outcomes of the Phase 2 Study in Adolescent Patients With Stargardt Disease
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2024
Suprachoroidal Delivery of Small Molecule Suspensions: Pre-Clinical Results Correlate to Clinical Trial Outcomes
James C. Major, MD, PhD FACS FASRS
Annual Meeting Talks
2021
Becoming a Clinical Trialist
Nancy M. Holekamp, MD, FASRS
Updates from the Field
2022

Category: Practice Management

See more